1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Polypoidal Choroidal Vasculopathy Global Clinical Trials Review, H2, 2015

Polypoidal Choroidal Vasculopathy Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Polypoidal Choroidal Vasculopathy Global Clinical Trials Review, H2, 2015" provides an overview of Polypoidal Choroidal Vasculopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Polypoidal Choroidal Vasculopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Polypoidal Choroidal Vasculopathy Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Polypoidal Choroidal Vasculopathy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Polypoidal Choroidal Vasculopathy to Ophthalmology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Polypoidal Choroidal Vasculopathy to Ophthalmology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Polypoidal Choroidal Vasculopathy 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
F. Hoffmann-La Roche Ltd. 31
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 31
Bayer AG 32
Clinical Trial Overview of Bayer AG 32
Regeneron Pharmaceuticals, Inc. 33
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 33
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Hawaii Pacific Health 35
Clinical Trial Overview of Hawaii Pacific Health 35
Pfizer Inc. 36
Clinical Trial Overview of Pfizer Inc. 36
OXiGENE, Inc. 37
Clinical Trial Overview of OXiGENE, Inc. 37
Oraya Therapeutics, Inc. 38
Clinical Trial Overview of Oraya Therapeutics, Inc. 38
Ophthotech Corp. 39
Clinical Trial Overview of Ophthotech Corp. 39
Lpath, Inc. 40
Clinical Trial Overview of Lpath, Inc. 40
Clinical Trial Overview of Top Institutes / Government 41
Southeast Retina Center 41
Clinical Trial Overview of Southeast Retina Center 41
Asan Medical Center 42
Clinical Trial Overview of Asan Medical Center 42
Federal University of Sao Paulo 43
Clinical Trial Overview of Federal University of Sao Paulo 43
Hyogo College Of Medicine 44
Clinical Trial Overview of Hyogo College Of Medicine 44
Kagawa University 45
Clinical Trial Overview of Kagawa University 45
Kyungpook National University 46
Clinical Trial Overview of Kyungpook National University 46
La Fondation Ophtalmologique Adolphe de Rothschild 47
Clinical Trial Overview of La Fondation Ophtalmologique Adolphe de Rothschild 47
Manhattan Eye Ear and Throat Hospital 48
Clinical Trial Overview of Manhattan Eye Ear and Throat Hospital 48
Medizinische Universitat Wien 49
Clinical Trial Overview of Medizinische Universitat Wien 49
Nihon University 50
Clinical Trial Overview of Nihon University 50
Five Key Clinical Profiles 51
Appendix 73
Abbreviations 73
Definitions 73
Research Methodology 74
Secondary Research 74
About GlobalData 75
Contact Us 75
Disclaimer 75
Source 76

List of Tables
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials by Region, 2015* 7
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 13
Proportion of Polypoidal Choroidal Vasculopathy to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 14
Polypoidal Choroidal Vasculopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Polypoidal Choroidal Vasculopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Polypoidal Choroidal Vasculopathy to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 17
Polypoidal Choroidal Vasculopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Polypoidal Choroidal Vasculopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Withdrawn Clinical Trials, 2015* 24
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Polypoidal Choroidal Vasculopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 31
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 32
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2015* 33
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 34
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Hawaii Pacific Health, 2015* 35
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 36
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by OXiGENE, Inc., 2015* 37
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Oraya Therapeutics, Inc., 2015* 38
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ophthotech Corp., 2015* 39
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Lpath, Inc., 2015* 40
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Southeast Retina Center, 2015* 41
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015* 42
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015* 43
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Hyogo College Of Medicine, 2015* 44
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Kagawa University, 2015* 45
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyungpook National University, 2015* 46
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by La Fondation Ophtalmologique Adolphe de Rothschild, 2015* 47
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Manhattan Eye Ear and Throat Hospital, 2015* 48
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medizinische Universitat Wien, 2015* 49
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Nihon University, 2015* 50

List of Figures
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Proportion of Polypoidal Choroidal Vasculopathy to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 14
Polypoidal Choroidal Vasculopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Polypoidal Choroidal Vasculopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Polypoidal Choroidal Vasculopathy to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 17
Polypoidal Choroidal Vasculopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Polypoidal Choroidal Vasculopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Polypoidal Choroidal Vasculopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 74

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.